Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.5.0.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2016
Aug. 12, 2016
Document And Entity Information    
Entity Registrant Name Boston Therapeutics, Inc.  
Entity Central Index Key 0001473579  
Document Type 10-Q  
Document Period End Date Jun. 30, 2016  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   44,319,507
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2016